Get notified when ZURA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure Of Cfo (new) — The Chief Financial Officer was separated from the company on April 20, 2026, though the company explicitly states it was not related to financial or operational disagreements.
Zura Bio CFO Eric Hyllengren separated; VP Finance Marlyn Mathew promoted to principal financial officer
Filed April 23, 2026 · Period ending April 20, 2026 · ~1 min read
Key Changes
-
high
CFO Eric Hyllengren was separated from the company on April 20, 2026. The company states the departure was not related to financial results, operations, or any disagreements about reporting practices.
Item 5.02 verify on EDGAR → -
high
Marlyn Mathew, VP of Finance and Accounting since June 2022, was immediately appointed principal financial and accounting officer with annual salary increased to $366,415.
Item 5.02 verify on EDGAR → -
medium
Mathew brings relevant experience as Controller at Immunovant (2019-2022) and has been with Zura Bio for nearly four years, suggesting continuity in financial leadership.
Item 5.02 verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade ZURA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify